BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 23418753)

  • 1. Sphingosine 1-phosphate release from platelets during clot formation: close correlation between platelet count and serum sphingosine 1-phosphate concentration.
    Ono Y; Kurano M; Ohkawa R; Yokota H; Igarashi K; Aoki J; Tozuka M; Yatomi Y
    Lipids Health Dis; 2013 Feb; 12():20. PubMed ID: 23418753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sphingosine 1-phosphate induces platelet activation through an extracellular action and shares a platelet surface receptor with lysophosphatidic acid.
    Yatomi Y; Yamamura S; Ruan F; Igarashi Y
    J Biol Chem; 1997 Feb; 272(8):5291-7. PubMed ID: 9030602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sphingosine-1-phosphate: a platelet-activating sphingolipid released from agonist-stimulated human platelets.
    Yatomi Y; Ruan F; Hakomori S; Igarashi Y
    Blood; 1995 Jul; 86(1):193-202. PubMed ID: 7795224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sphingosine 1-phosphate is a blood constituent released from activated platelets, possibly playing a variety of physiological and pathophysiological roles.
    Igarashi Y; Yatomi Y
    Acta Biochim Pol; 1998; 45(2):299-309. PubMed ID: 9821862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma sphingosine 1-phosphate metabolism and analysis.
    Yatomi Y
    Biochim Biophys Acta; 2008 Mar; 1780(3):606-11. PubMed ID: 17980708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sphingosine 1-phosphate as a major bioactive lysophospholipid that is released from platelets and interacts with endothelial cells.
    Yatomi Y; Ohmori T; Rile G; Kazama F; Okamoto H; Sano T; Satoh K; Kume S; Tigyi G; Igarashi Y; Ozaki Y
    Blood; 2000 Nov; 96(10):3431-8. PubMed ID: 11071638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum.
    Yatomi Y; Igarashi Y; Yang L; Hisano N; Qi R; Asazuma N; Satoh K; Ozaki Y; Kume S
    J Biochem; 1997 May; 121(5):969-73. PubMed ID: 9192741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N,N-dimethylsphingosine inhibition of sphingosine kinase and sphingosine 1-phosphate activity in human platelets.
    Yatomi Y; Ruan F; Megidish T; Toyokuni T; Hakomori S; Igarashi Y
    Biochemistry; 1996 Jan; 35(2):626-33. PubMed ID: 8555236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sphingosine 1-phosphate breakdown in platelets.
    Yatomi Y; Yamamura S; Hisano N; Nakahara K; Igarashi Y; Ozaki Y
    J Biochem; 2004 Oct; 136(4):495-502. PubMed ID: 15625319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphingosine 1-phosphate: synthesis and release.
    Yatomi Y; Ozaki Y; Ohmori T; Igarashi Y
    Prostaglandins Other Lipid Mediat; 2001 Apr; 64(1-4):107-22. PubMed ID: 11324700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple mechanisms linked to platelet activation result in lysophosphatidic acid and sphingosine 1-phosphate generation in blood.
    Sano T; Baker D; Virag T; Wada A; Yatomi Y; Kobayashi T; Igarashi Y; Tigyi G
    J Biol Chem; 2002 Jun; 277(24):21197-206. PubMed ID: 11929870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma sphingosine-1-phosphate measurement in healthy subjects: close correlation with red blood cell parameters.
    Ohkawa R; Nakamura K; Okubo S; Hosogaya S; Ozaki Y; Tozuka M; Osima N; Yokota H; Ikeda H; Yatomi Y
    Ann Clin Biochem; 2008 Jul; 45(Pt 4):356-63. PubMed ID: 18583619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sphingosine 1-phosphate inhibits migration of RBL-2H3 cells via S1P2: cross-talk between platelets and mast cells.
    Yokoo E; Yatomi Y; Takafuta T; Osada M; Okamoto Y; Ozaki Y
    J Biochem; 2004 Jun; 135(6):673-81. PubMed ID: 15213242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of sphingosine derivatives in human platelets: inducible formation of free sphingosine.
    Hisano N; Yatomi Y; Fujino MA; Igarashi Y; Kume S; Ozaki Y
    J Biochem; 1998 Feb; 123(2):263-8. PubMed ID: 9538201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Elucidation of the functional roles of lysophospholipid mediators and its application in laboratory medicine].
    Yatomi Y
    Rinsho Byori; 2006 Jul; 54(7):720-31. PubMed ID: 16913663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced release of sphingosine-1-phosphate from hypercholesterolemic platelets: role in development of hypercholesterolemic atherosclerosis.
    Son DJ; Lee HW; Shin HW; Lee JJ; Yoo HS; Kim TJ; Yun YP; Hong JT
    Prostaglandins Leukot Essent Fatty Acids; 2008 Jun; 78(6):383-90. PubMed ID: 18571912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of sphingosine and sphingosine 1-phosphate generation in human platelets.
    Tani M; Sano T; Ito M; Igarashi Y
    J Lipid Res; 2005 Nov; 46(11):2458-67. PubMed ID: 16061940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alkaline ceramidase 2 is essential for the homeostasis of plasma sphingoid bases and their phosphates.
    Li F; Xu R; Low BE; Lin CL; Garcia-Barros M; Schrandt J; Mileva I; Snider A; Luo CK; Jiang XC; Li MS; Hannun YA; Obeid LM; Wiles MV; Mao C
    FASEB J; 2018 Jun; 32(6):3058-3069. PubMed ID: 29401619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sphingosine 1-phosphate in vascular biology: possible therapeutic strategies to control vascular diseases.
    Yatomi Y
    Curr Pharm Des; 2006; 12(5):575-87. PubMed ID: 16472149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sphingosine 1-phosphate formation and intracellular Ca2+ mobilization in human platelets: evaluation with sphingosine kinase inhibitors.
    Yang L; Yatomi Y; Satoh K; Igarashi Y; Ozaki Y
    J Biochem; 1999 Jul; 126(1):84-9. PubMed ID: 10393324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.